Tab Cooney

Dr. Cooney's research interests include early phase clinical trial development for pediatric central nervous system (CNS) tumors, developmental therapeutics, disparities, and diversity. She has presented her findings, including initial results from a Phase 1 trial in Panobinostat for children with diffuse intrinsic pontine glioma (DIPG) and a DIPG historical cohort, at international and national meetings. Dr. Cooney is actively involved in several pediatric brain tumor consortia, holds leadership committee positions in the Pediatric Neuro-Oncology Consortium (PNOC) and Response Assessment in Pediatric Neuro-Oncology (RAPNO), and is a rising leader in her field.

Clinical Interests

• Clinical trial design
• Disparities
• Immunotherapies
• Novel therapies
• Protocol development
• Survivorship

Companies

• Director of Study Development Pediatric Neuro-Oncology Consortium (2022)
• Assistant Professor Harvard Medical School (2020)
• Director of Pediatric Neuro-Oncology Survivorship Dana-Farber Cancer Institute (2019)
• Assistant Professor, Pediatric Neuro-Oncology University of California, San Francisco (2019 — 2019)
• Attending Pediatric Neuro-Oncologist UCSF Benioff Children's Physicians (2017 — 2019)
• Pediatric Neuro-Oncology Fellow Stanford University (2016 — 2017)
• Pediatric Hematology/Oncology/Stem Cell Transplantation Fellow Stanford University (2013 — 2016)
• Pediatric Resident UCSF Benioff Children's Hospital Oakland (2010 — 2013)

Education

• Master’s Degree Stanford University (2014 — 2016)
• Doctor of Medicine (M.D.) University of South Florida (2006 — 2010)
• Bachelor’s Degree Duke University (2002 — 2006)